These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1327268)

  • 1. Prevention of kainate-induced excitotoxicity by a purine analogue.
    MacGregor DG; Stone TW
    Neuroreport; 1992 Jun; 3(6):536-8. PubMed ID: 1327268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.
    MacGregor DG; Miller WJ; Stone TW
    Br J Pharmacol; 1993 Sep; 110(1):470-6. PubMed ID: 8220909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.
    MacGregor DG; Stone TW
    Br J Pharmacol; 1993 Jun; 109(2):316-21. PubMed ID: 8358536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of purine protection against kainate-induced increase in hippocampal [3H]-PK11195 binding.
    Miller WJ; MacGregor DG; Stone TW
    Brain Res Bull; 1994; 34(2):133-6. PubMed ID: 8044687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade by 1,3-dipropyl-8-cyclopentylxanthine (CPX) of purine protection against kainate neurotoxicity.
    Macgregor DG; Stone TW
    Brain Res; 1994 May; 644(2):339-42. PubMed ID: 8050046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A purine analogue reduces kainate neurotoxicity in vivo.
    MacGregor DG; Chishti SK; Stone TW
    Biochem Soc Trans; 1993 Feb; 21(1):12S. PubMed ID: 8383603
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention by a purine analogue of kainate-induced neuropathology in rat hippocampus.
    MacGregor DG; Jones PA; Maxwell WL; Graham DI; Stone TW
    Brain Res; 1996 Jun; 725(1):115-20. PubMed ID: 8828594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by an adenosine analogue against kainate-induced extrahippocampal neuropathology.
    MacGregor DG; Graham DI; Jones PA; Stone TW
    Gen Pharmacol; 1998 Aug; 31(2):233-8. PubMed ID: 9688465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists.
    MacGregor DG; Graham DI; Stone TW
    Exp Neurol; 1997 Nov; 148(1):110-23. PubMed ID: 9398454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central adenosinergic system involvement in ethanol-induced motor incoordination in mice.
    Dar MS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1202-9. PubMed ID: 2262902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an inhibitory A1 subtype adenosine receptor on pancreatic insulin-secreting cells.
    Hillaire-Buys D; Bertrand G; Gross R; Loubatières-Mariani MM
    Eur J Pharmacol; 1987 Apr; 136(1):109-12. PubMed ID: 3297737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus.
    MacGregor DG; Higgins MJ; Jones PA; Maxwell WL; Watson MW; Graham DI; Stone TW
    Brain Res; 1996 Jul; 727(1-2):133-44. PubMed ID: 8842391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in noradrenaline release and in beta receptor number in rat hippocampus following long-term treatment with theophylline or L-phenylisopropyladenosine.
    Fredholm BB; Jonzon B; Lindgren E
    Acta Physiol Scand; 1984 Sep; 122(1):55-9. PubMed ID: 6095597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylxanthine discrimination in the rat: possible benzodiazepine and adenosine mechanisms.
    Holloway FA; Modrow HE; Michaelis RC
    Pharmacol Biochem Behav; 1985 May; 22(5):815-24. PubMed ID: 2989946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptors in myelin fractions and subfractions: the effect of the agonist (R)-phenylisopropyladenosine on myelin membrane microviscosity.
    Casadó V; Mallol J; Lluis C; Franco R; Canela EI
    J Neurochem; 1991 Nov; 57(5):1623-9. PubMed ID: 1919578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine.
    Fernandez M; Svenningsson P; Fredholm BB
    Life Sci; 1996; 58(9):769-76. PubMed ID: 8632724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of adenosine receptors in guinea-pig isolated left atria.
    Jahnel U; Nawrath H
    Br J Pharmacol; 1989 Aug; 97(4):1182-90. PubMed ID: 2790380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline.
    Wu SN; Linden J; Visentin S; Boykin M; Belardinelli L
    Circ Res; 1989 Oct; 65(4):1066-77. PubMed ID: 2551526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation and desensitization of A1-adenosine receptors in embryonic chicken heart.
    Shryock J; Patel A; Belardinelli L; Linden J
    Am J Physiol; 1989 Feb; 256(2 Pt 2):H321-7. PubMed ID: 2916668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A1 and non-A1 receptors: intracellular analysis of the actions of adenosine agonists and antagonists in rat hippocampal neurons.
    Ameri A; Jurna I
    Brain Res; 1991 Apr; 546(1):69-78. PubMed ID: 1855150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.